Transplant Glomerulopathy
4 clinical trials · Condition
◉ Watch Transplant Glomerulopathy
| Record | Firm | Date |
|---|---|---|
| Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant (NCT03380962) | Stanley Jordan, MD | 2018-02-27 |
| Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant (NCT03380377) | Stanley Jordan, MD | 2018-02-21 |
| Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar (NCT02546492) | University of Maryland, Baltimore | 2016-08-01 |
| Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients (NCT02057523) | University of Illinois at Chicago | 2014-09-01 |
Track Transplant Glomerulopathy automatically
Every clearance here is in the API, with alerts when new ones post.